Finances: Page 6
-
Margins improve at nonprofit hospitals in 2024, but headwinds loom: Fitch
The median operating margin for providers that ended their fiscal years early was 1.2% last year, compared with -0.5% in 2023. However, potential Medicaid cuts could strain provider finances.
By Emily Olsen • March 31, 2025 -
Solventum cuts 800 positions
CEO Bryan Hanson told investors last week that the restructuring plan would save the medical supply and health IT company $120 million annually.
By Ricky Zipp • March 26, 2025 -
Sponsored by RxSense
The future of pharmacy benefits: The shift to insourcing PBM services
The pharmacy benefit landscape is shifting. With rising costs, limited transparency, and rigid structures imposed by legacy pharmacy benefit managers (PBMs), organizations are considering a bold move—bringing their PBM operations in-house.
March 24, 2025 -
Optum Rx is reforming how it pays pharmacies
The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid. Pharmacy groups say that depends on the specifics of Optum Rx’s plan.
By Rebecca Pifer • March 21, 2025 -
Veradigm releases long-awaited financial results
The health IT vendor hadn’t filed quarterly or annual reports since November 2022. Veradigm was delisted from Nasdaq for failing to comply with financial reporting requirements last year.
By Emily Olsen • March 20, 2025 -
Cigna closes $3.7B sale of Medicare business to HCSC
The deal, which removes Cigna from the volatile Medicare Advantage market, closed a little over a year after being announced.
By Rebecca Pifer • March 20, 2025 -
Optum Rx says it will eliminate 10% of prior authorizations
The massive pharmacy benefit manager plans to stop requiring coverage reauthorizations for roughly 80 drugs used to treat migraines, multiple sclerosis, high cholesterol and more.
By Rebecca Pifer • March 19, 2025 -
Providers contend with changes in Washington in 2025
The nation’s leading for-profit health systems are closely monitoring changes to Medicaid funding and bracing for possible cuts to state supplemental payment programs this year.
By Susanna Vogel • March 14, 2025 -
Virtual physical therapy company Hinge Health files for IPO
The digital health IPO market has slowed to a crawl in recent years, but it could be poised for a turnaround in 2025, experts say.
By Emily Olsen • March 12, 2025 -
Medicaid expansion cuts could hit provider revenue, spike uncompensated care: report
If states end their expansion programs in response to funding cuts, spending on healthcare services would fall by nearly $80 billion and uncompensated care costs would rise by $19 billion in 2026, according to new research.
By Emily Olsen • March 12, 2025 -
Sponsored by Zelis
5 considerations for health plans evaluating the VOI of healthcare technology
Health plans must shift from ROI to VOI, evaluating tech investments for long-term, holistic value.
By Jay Deady, President of Price Optimization, Zelis • March 3, 2025 -
UHS’ income soars in 2024 on behavioral health volume
Still, executives addressed concerns about potential changes to federal healthcare policy that could impact the provider’s bottom line, including cuts to Medicaid.
By Susanna Vogel • Feb. 28, 2025 -
Deep Dive
Insurers closed out 2024 on shaky footing
Operating income fell for all but two major payers’ insurance divisions in the fourth quarter. And 2025 may be no better, after many insurers released outlooks suggesting medical costs will continue to rise.
By Rebecca Pifer • Feb. 25, 2025 -
Veradigm changes up board of directors
The health IT vendor was delisted from trading on Nasdaq last year for failing to file timely financial reports. Last month, the company ended a strategic review without finding a buyer.
By Emily Olsen • Feb. 24, 2025 -
Private equity investment in healthcare remained steady in 2024: report
Investment could rise in 2025 if interest rates decline and the Trump administration is friendly to private equity firms.
By Susanna Vogel • Feb. 24, 2025 -
CHS’ losses widen in 2024
The hospital operator said divestitures, medical specialist fees and payer denials pressured the system last year.
By Susanna Vogel • Feb. 20, 2025 -
Amwell touts military contract deployment wins in Q4
The telehealth vendor posted a net loss again last year, but said it plans to achieve positive cash flow by 2026.
By Susanna Vogel • Feb. 13, 2025 -
GOP calls for $1.5T in cuts, much of which could come from healthcare
House Republicans unveiled their budget wish list last week, which directs the Energy and Commerce Committee — which oversees Medicare and Medicaid — to find $880 billion in savings.
By Rebecca Pifer • Feb. 13, 2025 -
Tenet has ‘outstanding’ 2024, addresses policy changes in Washington
Health system leaders said Tenet is mostly insulated from proposed policy changes like Medicaid cuts due to its focus on ambulatory surgical centers.
By Susanna Vogel • Feb. 13, 2025 -
CVS slashes profit in 2024 as high medical costs hit Aetna
However, the healthcare giant beat Wall Street expectations for earnings and revenue in the fourth quarter, sending its stock soaring on Wednesday.
By Emily Olsen • Feb. 12, 2025 -
Large healthcare companies are redistributing most of their profits to shareholders, study finds
Researchers suggested that policymakers encourage reinvestment of capital into patient care and limit share buybacks based on the findings.
By Rebecca Pifer • Feb. 12, 2025 -
Mass General Brigham to conduct largest layoffs in its history
MGB said the layoffs are necessary to get ahead of an anticipated budget shortfall of $250 million over the next two years.
By Susanna Vogel • Feb. 11, 2025 -
Humana’s 2024 profit slashed in half amid higher medical spending
The massive insurer now expects to lose 550,000 Medicare Advantage members — roughly one-tenth of its individual MA footprint — this year as a result of plan cuts.
By Rebecca Pifer • Feb. 11, 2025 -
Kaiser’s 2024 earnings show ROI of Risant Health spinoff
Risant acquisitions accounted for about half of Kaiser’s net income in 2024.
By Susanna Vogel • Feb. 10, 2025 -
Walgreens offloads more Cencora shares
The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10%.
By Rebecca Pifer • Feb. 7, 2025